Qure.ai bags second FDA clearance for Brain CT scan AI
NEW YORK, Aug. 19, 2021 /PRNewswire/ -- Leading medical image AI provider Qure.ai has announced US FDA 510(k) clearance for its Brain CT quantification product qER-Quant.
- NEW YORK, Aug. 19, 2021 /PRNewswire/ -- Leading medical image AI provider Qure.ai has announced US FDA 510(k) clearance for its Brain CT quantification product qER-Quant.
- CT scans are the most widely used toexam for brain injuries and are used to help diagnose millions of patients that visit the emergency room every year.
- AI assistance speeds up treatment and transfer decisions, helps monitor patients more closely and reduces the chances of diagnostic errors.
- "This FDA clearance adds quantification, outlining and measurement capabilities to Qure.ai's first clearance for triage and notification of critical brain abnormalities.